Salaris, S C <br/><br/>
Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia/reperfusion injury.  [electronic resource] 

 -  Biochemical pharmacology  Jul 1991 
 - 499-506 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/0006-2952(91)90311-r  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--pharmacology<br/>Hypoxanthine<br/>Hypoxanthines--metabolism<br/>In Vitro Techniques<br/>Kidney--drug effects<br/>Lipid Peroxidation<br/>Liver--drug effects<br/>Methylene Blue--metabolism<br/>Models, Biological<br/>Oxidation-Reduction<br/>Rats<br/>Reperfusion Injury--prevention & control<br/>Succimer<br/>Superoxides--metabolism<br/>Xanthine<br/>Xanthine Oxidase--antagonists & inhibitors<br/>Xanthines--metabolism